News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
525,926 Results
Type
Article (33398)
Company Profile (84)
Press Release (492441)
Multimedia
Podcasts (56)
Webinars (11)
Section
Business (144390)
Career Advice (984)
Deals (26138)
Drug Delivery (75)
Drug Development (62325)
Employer Resources (79)
FDA (14394)
Job Trends (10946)
News (252975)
Policy (25488)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (2086)
Accelerated approval (26)
Adcomms (15)
Allergies (127)
Alliances (34777)
ALS (134)
Alzheimer's disease (1333)
Antibody-drug conjugate (ADC) (245)
Approvals (14721)
Artificial intelligence (423)
Autoimmune disease (143)
Automation (21)
Bankruptcy (257)
Best Places to Work (8901)
BIOSECURE Act (7)
Biosimilars (115)
Biotechnology (60)
Bladder cancer (146)
Brain cancer (53)
Breast cancer (548)
Cancer (4178)
Cardiovascular disease (336)
Career advice (884)
Career pathing (20)
CAR-T (235)
CDC (36)
Celiac Disease (2)
Cell therapy (589)
Cervical cancer (35)
Clinical research (54976)
Collaboration (1244)
Company closure (1)
Compensation (448)
Complete response letters (33)
COVID-19 (1992)
CRISPR (58)
C-suite (753)
Cystic fibrosis (100)
Data (5620)
Decentralized trials (2)
Denatured (27)
Depression (124)
Diabetes (412)
Diagnostics (5105)
Digital health (41)
Diversity (10)
Diversity, equity & inclusion (23)
Drug discovery (174)
Drug pricing (124)
Drug shortages (29)
Duchenne muscular dystrophy (191)
Earnings (60825)
Editorial (48)
Employer branding (8)
Employer resources (73)
Events (74044)
Executive appointments (866)
FDA (17292)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (10)
Frontotemporal dementia (18)
Funding (1142)
Gene editing (135)
Generative AI (38)
Gene therapy (438)
GLP-1 (722)
Government (3805)
Grass and pollen (5)
Guidances (347)
Healthcare (15407)
HIV (53)
Huntington's disease (28)
IgA nephropathy (74)
Immunology and inflammation (157)
Immuno-oncology (46)
Indications (104)
Infectious disease (2202)
Inflammatory bowel disease (171)
Inflation Reduction Act (9)
Influenza (87)
Intellectual property (218)
Interviews (117)
IPO (12212)
IRA (36)
Job creations (2343)
Job search strategy (775)
JPM (29)
Kidney cancer (14)
Labor market (56)
Layoffs (270)
Leadership (19)
Legal (5324)
Liver cancer (80)
Longevity (9)
Lung cancer (585)
Lymphoma (332)
Machine learning (29)
Management (24)
Manufacturing (507)
MASH (138)
Medical device (13862)
Medtech (13917)
Mergers & acquisitions (14843)
Metabolic disorders (1002)
Multiple sclerosis (142)
NASH (11)
Neurodegenerative disease (237)
Neuropsychiatric disorders (66)
Neuroscience (2340)
NextGen: Class of 2026 (4864)
Non-profit (3247)
Now hiring (37)
Obesity (436)
Opinion (198)
Ovarian cancer (151)
Pain (178)
Pancreatic cancer (210)
Parkinson's disease (232)
Partnered (21)
Patents (419)
Patient recruitment (462)
Peanut (46)
People (46462)
Pharmaceutical (26)
Pharmacy benefit managers (22)
Phase 1 (16796)
Phase 2 (24063)
Phase 3 (18646)
Pipeline (4735)
Policy (190)
Postmarket research (1924)
Preclinical (6209)
Press Release (36)
Prostate cancer (218)
Psychedelics (37)
Radiopharmaceuticals (243)
Rare diseases (644)
Real estate (3624)
Recruiting (35)
Regulatory (20216)
Reports (29)
Research institute (1960)
Resumes & cover letters (117)
Rett syndrome (25)
RNA editing (9)
RSV (58)
Schizophrenia (133)
Series A (185)
Series B (141)
Service/supplier (3)
Sickle cell disease (71)
Special edition (12)
Spinal muscular atrophy (123)
Sponsored (30)
Startups (2584)
State (1)
Stomach cancer (14)
Supply chain (83)
Tariffs (38)
The Weekly (28)
Vaccines (693)
Venture capital (51)
Weight loss (283)
Women's health (70)
Worklife (10)
Date
Today (40)
Last 7 days (415)
Last 30 days (1769)
Last 365 days (23533)
2026 (3066)
2025 (23907)
2024 (27986)
2023 (32029)
2022 (41319)
2021 (44434)
2020 (43310)
2019 (36145)
2018 (27482)
2017 (25028)
2016 (23539)
2015 (27425)
2014 (20744)
2013 (17044)
2012 (18297)
2011 (18892)
2010 (17364)
Location
Africa (528)
Alabama (55)
Alaska (4)
Arizona (206)
Arkansas (10)
Asia (34306)
Australia (6741)
California (8594)
Canada (2840)
China (964)
Colorado (376)
Connecticut (425)
Delaware (296)
Europe (67739)
Florida (1413)
Georgia (275)
Hawaii (1)
Idaho (43)
Illinois (755)
India (64)
Indiana (423)
Iowa (11)
Japan (396)
Kansas (99)
Kentucky (28)
Louisiana (21)
Maine (63)
Maryland (1168)
Massachusetts (5942)
Michigan (216)
Minnesota (510)
Mississippi (5)
Missouri (111)
Montana (25)
Nebraska (23)
Nevada (113)
New Hampshire (77)
New Jersey (2584)
New Mexico (16)
New York (2452)
North Carolina (1175)
North Dakota (5)
Northern California (4194)
Ohio (263)
Oklahoma (12)
Oregon (32)
Pennsylvania (1889)
Puerto Rico (21)
Rhode Island (40)
South America (779)
South Carolina (62)
Southern California (3377)
Tennessee (144)
Texas (1451)
United States (31628)
Utah (265)
Virginia (216)
Washington D.C. (62)
Washington State (733)
West Virginia (4)
Wisconsin (87)
Wyoming (1)
525,926 Results for "atcor medical holdings limited".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Haemonetics Acquires Vivasure Medical Limited
January 9, 2026
·
5 min read
Press Releases
EXACT Therapeutics: Exercise of Warrants by GE Medical Holding AB
February 5, 2026
·
2 min read
Press Releases
Nemysis Limited Announces Investment by Kolinpharma Through Its Parent Company IGEA Holding S.p.A.
November 14, 2025
·
2 min read
Gene editing
FDA Lifts One of Two Clinical Holds on Intellia’s ATTR Gene Editing Program
After a patient safety signal and then death, the FDA in October 2025 placed holds on two of the company’s CRISPR programs for hereditary transthyretin amyloidosis.
January 27, 2026
·
2 min read
·
Dan Samorodnitsky
Press Releases
Lee’s Pharmaceutical Holdings Limited Acquires Staccato® One Breath Technology® Platform and Assets, Driving Pipeline Expansion and Advancing Global Partnership with UCB Through Acquired Rights
December 10, 2025
·
6 min read
Press Releases
YD Bio Limited Enters into Binding Letter of Intent to Acquire Safe Save Medical Cell Sciences & Technology Co., Ltd., Bolstering Leadership in Advanced Immunocell Therapy
January 29, 2026
·
6 min read
ADCs
Lung Cancer Trial to Proceed After FDA Releases Hold on Merck, Daiichi’s ADC
The FDA initially placed the Phase III IDeate-Lung02 study on hold due to a “higher than expected” number of deaths in patients treated with ifinatamab deruxtecan.
January 13, 2026
·
3 min read
·
Tristan Manalac
Business
ATCOR Medical Enters into Partnership Agreement with Datacubed Health to Increase Patient Retention and Engagement in Decentralized Clinical Trials
ATCOR Medical today announces it has entered into a partnership agreement with Datacubed Health, a leading eClinical technology company, advancing access to healthcare for everyone, everywhere.
June 26, 2023
·
4 min read
Press Releases
Creative Medical Technology Holdings Achieves Second WHO INN Milestone, Strengthening Global Regulatory Positioning Across Expanding Cell Therapy Pipeline
February 10, 2026
·
3 min read
Press Releases
OSR Holdings Completes Woori IO Acquisition, Secures Long-Term Shareholder Alignment, and Reviews Strategic Combination of Medical Device Subsidiaries
January 28, 2026
·
3 min read
1 of 52,593
Next
